Insider Transactions in Q1 2025 at Passage Bio, Inc. (PASG)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 11
2025
|
Kathleen Borthwick CFO |
SELL
Open market or private sale
|
Direct |
3,183
-7.16%
|
$0
$0.53 P/Share
|
|
Feb 10
2025
|
Kathleen Borthwick CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+15.25%
|
-
|
|
Jan 14
2025
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
79,024
-1.11%
|
$0
$0.6 P/Share
|
|
Jan 13
2025
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
17,986
-0.25%
|
$0
$0.64 P/Share
|
|
Jan 10
2025
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
126,209
-1.74%
|
$0
$0.66 P/Share
|
|
Jan 08
2025
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
75,007
-1.02%
|
$0
$0.68 P/Share
|
|
Jan 07
2025
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
52,536
-0.71%
|
$0
$0.71 P/Share
|
|
Jan 06
2025
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,481
-0.26%
|
$0
$0.77 P/Share
|